Search Page

1

Cite

Share

CX3CL1 Signaling in the Tumor Microenvironment.

Conroy MJ, Lysaght J. Conroy MJ, et al. Adv Exp Med Biol. 2020;1231:1-12. doi: 10.1007/978-3-030-36667-4_1. Adv Exp Med Biol. 2020. PMID: 32060841 Review.

Cite

Share

2

Cite

Share

Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.

Mockler MB, Conroy MJ, Lysaght J. Mockler MB, et al. Among authors: conroy mj. Front Oncol. 2014 May 16;4:107. doi: 10.3389/fonc.2014.00107. eCollection 2014. Front Oncol. 2014. PMID: 24904823 Free PMC article. Review.

Cite

Share

3

Cite

Share

Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection.

Conroy MJ, Mac Nicholas R, Taylor M, O'Dea S, Mulcahy F, Norris S, Doherty DG. Conroy MJ, et al. Viral Immunol. 2015 May;28(4):201-8. doi: 10.1089/vim.2014.0133. Epub 2015 Mar 19. Viral Immunol. 2015. PMID: 25789722

Cite

Share

4

Cite

Share

Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma.

Kavanagh ME, Conroy MJ, Clarke NE, Gilmartin NT, O'Sullivan KE, Feighery R, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, O'Sullivan J, Lysaght J. Kavanagh ME, et al. Among authors: conroy mj. Cancer Lett. 2016 Jan 1;370(1):117-24. doi: 10.1016/j.canlet.2015.10.019. Epub 2015 Oct 28. Cancer Lett. 2016. PMID: 26519754

Cite

Share

5

Cite

Share

Obesity-associated cancer: an immunological perspective.

Conroy MJ, Dunne MR, Donohoe CL, Reynolds JV. Conroy MJ, et al. Proc Nutr Soc. 2016 May;75(2):125-38. doi: 10.1017/S0029665115004176. Epub 2015 Nov 16. Proc Nutr Soc. 2016. PMID: 26567898 Review.

Cite

Share

6

Cite

Share

CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity-associated cancer.

Conroy MJ, Galvin KC, Kavanagh ME, Mongan AM, Doyle SL, Gilmartin N, O'Farrelly C, Reynolds JV, Lysaght J. Conroy MJ, et al. Immunol Cell Biol. 2016 Jul;94(6):531-7. doi: 10.1038/icb.2016.26. Epub 2016 Apr 5. Immunol Cell Biol. 2016. PMID: 27046081

Cite

Share

7

Cite

Share

The microenvironment of visceral adipose tissue and liver alter natural killer cell viability and function.

Conroy MJ, Fitzgerald V, Doyle SL, Channon S, Useckaite Z, Gilmartin N, O'Farrelly C, Ravi N, Reynolds JV, Lysaght J. Conroy MJ, et al. J Leukoc Biol. 2016 Dec;100(6):1435-1442. doi: 10.1189/jlb.5AB1115-493RR. Epub 2016 Jun 30. J Leukoc Biol. 2016. PMID: 27365528

Cite

Share

8

Cite

Share

Extratumoral PD-1 blockade does not perpetuate obesity-associated inflammation in esophageal adenocarcinoma.

Galvin KC, Conroy MJ, Doyle SL, Dunne MR, Fahey R, Foley E, O'Sullivan KE, Doherty DG, Geoghegan JG, Ravi N, O'Farrelly C, Reynolds JV, Lysaght J. Galvin KC, et al. Among authors: conroy mj. Cancer Lett. 2018 Apr 1;418:230-238. doi: 10.1016/j.canlet.2018.01.039. Epub 2018 Jan 12. Cancer Lett. 2018. PMID: 29339209

Cite

Share

9

Cite

Share

Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8⁺ T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients.

Conroy MJ, Maher SG, Melo AM, Doyle SL, Foley E, Reynolds JV, Long A, Lysaght J. Conroy MJ, et al. Front Immunol. 2018 Aug 13;9:1867. doi: 10.3389/fimmu.2018.01867. eCollection 2018. Front Immunol. 2018. PMID: 30150990 Free PMC article.

Cite

Share

10

Cite

Share

Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma.

Kavanagh ME, Conroy MJ, Clarke NE, Gilmartin NT, Feighery R, MacCarthy F, O'Toole D, Ravi N, Reynolds JV, O' Sullivan J, Lysaght J. Kavanagh ME, et al. Among authors: conroy mj. Cancer Microenviron. 2019 Apr;12(1):57-66. doi: 10.1007/s12307-019-00220-6. Epub 2019 Mar 4. Cancer Microenviron. 2019. PMID: 30834503 Free PMC article.

Cite

Share